Application of the SCAI classification in a cohort of patients with cardiogenic shock

Benedikt Schrage1,2, Salim Dabboura1, Isabell Yan1

  • 1Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.

Insights

The Society of Cardiovascular Angiography and Interventions (SCAI) classification for cardiogenic shock (CS) effectively predicts 30-day survival. Higher SCAI classes correlate with decreased survival rates in CS patients.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Interventional Cardiology

Background:

  • The Society of Cardiovascular Angiography and Interventions (SCAI) introduced a new classification system for cardiogenic shock (CS).
  • This system categorizes patients into five distinct subgroups.

Purpose of the Study:

  • To apply the SCAI classification to a large cohort of patients experiencing CS.
  • To assess the classification's ability to predict 30-day survival rates.

Main Methods:

  • The SCAI CS classification was applied to 1,007 consecutive patients with CS or large myocardial infarction (MI).
  • Data were collected between October 2009 and October 2017.
  • Logistic regression analysis was used to determine the association between SCAI classification and 30-day all-cause mortality.

Main Results:

  • The study included 1,007 patients with a mean age of 67 years; 72% were male.
  • Overall 30-day survival was 50.6%.
  • Survival probabilities decreased significantly with higher SCAI classes (Class A: 96.4% to Class E: 22.6%), with a statistically significant association (p < .01).

Conclusions:

  • The SCAI classification of cardiogenic shock is significantly associated with 30-day survival in a large clinical cohort.
  • These findings support the validity of the SCAI CS classification.
  • Further validation in a prospective trial is recommended.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
252
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
488
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
446
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
431
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
181
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K